Pneumococcal conjugate vaccines

Recommendations to assure the quality, safety and efficacy of pneumococcal conjugate vaccines-proposed replacement of TRS 927, Annex 2, ECBS, 19 to 23 October 2009


  • Working Group Meeting to develop WHO Guidelines on regulatory preparedness for vaccine non-producing countries in response to Pandemic Influenza emergency, 9-11 June 2015, Tunis Conference Centre, Tunisia


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971